Live Webinar

Hypothyroidism, the liver and the kidneys

Launch 5 December 2025
From 15.00 to 16.00 CET

WATCH THE ON DEMAND WEBINAR

Pre-webinar interview

Post-webinar infographic

Overview

Thyroid hormones maintain metabolic homeostasis, so thyroid dysfunction impacts multiple body systems, which in turn influence each other. This webinar explores the effects of hypothyroidism on liver function, kidney function and cardiovascular function and how imbalance in each of these areas impacts each of the others, collectively contributing, with insulin resistance, to metabolic dysfunction. The liver and the thyroid are intimately linked [Ritter, 2020; Hidalgo-Álvarez, 2023; Mendoza, 2021, [Piantanida, 2020]. Patients with hypothyroidism have suboptimal cholesterol and lipid levels [Ritter, 2020] and are at higher risk of developing Non-Alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) than those who are euthyroid [Notariza, 2019; Targher, 2024]. Hepatic dysfunction associated with hypothyroidism is usually reverted by normalizing thyroid status, but overlapping symptomatology between liver dysfunction and severe hypothyroidism may delay diagnosis and treatment of hypothyroidism [Yorke, 2024]. Hypothyroidism and hyperthyroidism both affect renal function by direct renal effects as well as hemodynamic, metabolic and cardiovascular effects [Iglesias, 2017]. This relationship is bidirectional. Most of the renal manifestations caused by thyroid dysfunction are reversible on treatment of the thyroid issues [Iglesias, 2017], although relevant clinical studies are scarce [Naguib, 2023]. Subclinical hypothyroidism in chronic and end-stage kidney disease patients increases their risk of cardiovascular disease morbidity and mortality above that of the general population [Iglesias, 2017; Spahia, 2023].Thyroid hormones, kidney function and liver function are intertwined – this webinar aims to explore and explain these interconnections.

Learning Objectives

At the end of the webinar, learners should be able to:

Target Audience

Endocrinologists and other healthcare professionals involved in the diagnosis and management of thyroid disorders.

Language

English with simultaneous translation into Spanish and Chinese.

Continuing Medical Education

The Hypothyroidism, the liver and the kidneys – Virtual, Italy 05/12/2025 – 05/12/2025
has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMSEACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

uems-eaccme-logo

The content of the Hypothyroidism, the liver and the kidneys has been certified by the CPD Certification Service as conforming to continuing professional development principles.

LIVE WEBINAR
Hypothyroidism, the liver and the kidneys

Launch 5 December 2025

from 15.00 to 16.00 CET

Faculty

Gabriela Brenta

Gabriela Brenta

Chief of the Thyroid Division
Dr Cesar Milstein Hospital and Assistant Professor
Medical School University of Buenos Aires
Buenos Aires, Argentina
Anthony Hollenberg

Anthony Hollenberg

President of Boston Medical Center (BMC) and
Professor of Medicine at Boston University Chobanian and
Avedisian School of Medicine
Boston (MA), USA
Salman Razvi

Salman Razvi

Senior Lecturer in Endocrinology at Newcastle University
Consultant Endocrinologist at Queen Elizabeth Hospital
Newcastle, UK

International Committee

Marcelo Vitale

Marcelo Vitale

President of the Argentine Society of Endocrinology and Metabolism (SAEM)
Specialist in Endocrinology, Nuclear Medicine, and Radioimmunoassay
Head of the Neuroendocrinology Section
Neurosurgery Unit, Santa Lucía Hospital
Buenos Aires, Argentina

Partnerships & Endorsements

With the Endorsement of

Agenda

AGENDA

Final Programme

Download

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Gabriela Brenta ·

Gabriela Brenta is Chief of the Thyroid Division of the Endocrinology Department of the Dr Cesar Milstein Hospital in Buenos Aires, and Assistant Professor at the Medical School of the University of Buenos Aires in Argentina. Alongside her clinical commitments, Dr Brenta is an active and well-published researcher – her main areas of scientific interest include the cardiovascular and metabolic effects of thyroid hormones, as well as nodular thyroid disease including thyroid cancers. Her professional affiliations include pro-secretary of the Argentine Society of Endocrinology and Metabolism (SAEM), as well as membership of the thyroid section of SAEM. Dr Brenta served as President of the Latin American Thyroid Society 2017–2019 and is currently a member of the Pregnancy and Thyroid Task Force and the Women in Thyroid (WIT) group of the American Thyroid Association. Dr Brenta is a member of the editorial committee of Thyroid, The Journal of Endocrinology Investigation, Revista Argentina de Endocrinología y Metabolismo, and Clinical Thyroidology.

· Anthony Hollenberg ·

Anthony Hollenberg is the President of Boston Medical Center (BMC) and Professor of Medicine at Boston University Chobanian and Avedisian School of Medicine. Dr. Hollenberg earned his medical degree from the University of Calgary and completed his residency in Internal Medicine at Beth Israel Deaconess Medical Center, where he also served as Chief Resident. He further specialized by completing a fellowship in Endocrinology, Diabetes, and Metabolism at Massachusetts General Hospital. Dr. Hollenberg is recognized for his groundbreaking research on thyroid disorders, focusing on the physiological and molecular mechanisms by which thyroid hormones regulate metabolism and body weight, as well as thyroid gland development.

· Salman Razvi ·

Salman Razvi is a Senior Lecturer in Endocrinology at Newcastle University and a Consultant Endocrinologist at Queen Elizabeth Hospital. His doctoral thesis was based on assessing cardiovascular risk in subclinical hypothyroidism. After this, he has continued to pursue research evaluating the action of thyroid hormones particularly on the cardiovascular system. The focus of his research has been on investigating the association of thyroid function with cardiovascular events in various populations. He is the chief investigator of several projects funded by various statutory funding bodies as well as charities. He has more than 110 peer-reviewed publications and book chapters mainly relating to thyroid dysfunction. His main research programmes include investigating the treatment of subclinical hypothyroidism with thyroid hormones in acute myocardial infarction and age-appropriate treatment of hypothyroidism in the elderly. Dr Razvi is also the Director of Research and Development at the Queen Elizabeth Hospital NHS Trust, Gateshead and the Metabolic and Endocrine Lead for the North East England Local Clinical Research Network. He is a member of the editorial board of JCEM, Thyroid, Frontiers in Endocrinology and Journal of Endocrinological Investigations.  In addition, Dr Razvi is a member of the executive committee of the European Thyroid Association, Programme Organising Committee of the British Society for Endocrinology and the medical advisor to the patient-led charity the British Thyroid Foundation.

· Marcelo Vitale ·

Marcelo Vitale is Specialist in Endocrinology, Nuclear Medicine, and Radioimmunoassay, with an extensive career in neuroendocrinology and pituitary disease. He currently serves as Head of the Neuroendocrinology Section of the Neurosurgery Unit at Santa Lucía Hospital, part of the Ministry of Health of the City of Buenos Aires, Argentina. Dr. Vitale is a Postgraduate Professor of Endocrinology at the National University of Buenos Aires and the current President of the Argentine Society of Endocrinology and Metabolism (SAEM) for the 2024–2025 term. Throughout his career, he has held several significant roles within SAEM, including Member of the Scientific Committee, Coordinator of the Neuroendocrinology Department, Member of the Editorial Committee of the Argentine Journal of Endocrinology and Metabolism (RAEM), and Member of the SAEM Recertification Committee in Endocrinology. He is Director of the Diploma Program in Pituitary Pathology at the Faculty of Medicine of the National University of Tucumán and has served as Co-Director of the Training and Continuing Education Courses in Neuroendocrinology offered by SAEM since 2005. Dr. Vitale is also a Founding Member of the Latin American Society of Neuroendocrinology (SLANE). A recognized contributor to academic and clinical endocrinology, Dr. Vitale has authored numerous papers presented at national and international congresses, as well as book chapters on neuroendocrinology in both Argentine and international medical texts. His work reflects a sustained commitment to advancing clinical practice, education, and scientific development in the field of neuroendocrinology.

Join our Newsletter!

Stay in the know with our CME updates

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.